1. Home >
  2. M&A >
  3. Add-on Acquisition >
  4. United States >
  5. California >
  6. Active Motif Acquires Amaryllis Nucleics

M&A Deal Summary

Active Motif Acquires Amaryllis Nucleics

On January 27, 2022, Active Motif acquired life science company Amaryllis Nucleics

Acquisition Highlights
  • This is Active Motif’s 2nd transaction in the Life Science sector.
  • This is Active Motif’s 2nd transaction in the United States.
  • This is Active Motif’s 2nd transaction in California.

M&A Deal Summary
Date 2022-01-27
Target Amaryllis Nucleics
Sector Life Science
Buyer(s) Active Motif
Deal Type Add-on Acquisition

Target

Amaryllis Nucleics

Oakland, California, United States
Amaryllis Nucleics focused on proprietary RNA Sequencing methods. RNA sequencing is vital for cutting-edge cancer diagnostics, pharmaceutical development, and food security, but the time and cost are major bottlenecks. Amaryllis Nucleics was founded in 2016 and is based in Oakland, California.

Search 214,557 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Active Motif

Carlsbad, California, United States
Category Company
Founded 1999
Sector Life Science
DESCRIPTION

Active Motif is a distributor of tools that enable epigenetics and gene regulation research. Active Motif was founded in 1999 and is based in Carlsbad, California.

DEAL STATS #
Overall 2 of 2
Sector: Life Science M&A 2 of 2
Type: Add-on Acquisition M&A Deals 2 of 2
State: California M&A 2 of 2
Country: United States M&A 2 of 2
Year: 2022 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-03-21 SwitchGear Genomics

Menlo Park, California, United States

SwitchGear Genomics, Inc. is a provider of research products for studying regulatory elements in the human genome.

Buy -
Mergr

Solution for

Product

Company

Legal